Aquinox to Present at 2018 UBS Global Healthcare C
Post# of 301275
VANCOUVER, British Columbia, May 16, 2018 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (“ Aquinox ”) (NASDAQ: AQXP ), a clinical-stage pharmaceutical company discovering and developing novel drug candidates to treat inflammation, inflammatory pain, and blood cancers, announced today that David Main, President & CEO, will provide a corporate update at the upcoming 2018 UBS Global Healthcare Conference in New York on Wednesday, May 23 rd 2018 .
Aquinox Presentation Details
Date: Wednesday, May 23 rd 2018 Time: 5:00 am Pacific Time / 8:00 am Eastern Time Location: New York, NY – Grand Hyatt New York
A live webcast and archive of the event will be available at:
https://cc.talkpoint.com/ubsx001/052118a_as/?...75_XVWH8N7
To ensure a timely connection to the webcast, it is recommended that users register at least 15 minutes prior to the scheduled start time. An archived version of the webcast will also be available on the Investor Relations page of the Aquinox website. The corporate overview being presented will be available following the presentation at www.aqxpharma.com .
About Aquinox Pharmaceuticals, Inc.
Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company developing novel therapeutics for chronic urological conditions marked by inflammation and pain. Aquinox's lead drug candidate, rosiptor (AQX-1125), is in Phase 3 development for the treatment of patients with interstitial cystitis/bladder pain syndrome (IC/BPS), a condition for which there are currently few FDA approved and/or effective treatment options. Aquinox is focused on leveraging its library of novel compounds that activate SHIP1 to develop therapeutics for application in inflammation, inflammatory pain, and blood cancers. For more information, please visit http://www.aqxpharma.com/ .
Investor Contact Info:
Brendan Payne
Associate Director, Investor Relations Aquinox Pharmaceuticals, Inc. 604.901.3019 ir@aqxpharma.com
Gitanjali Ogawa Vice President The Trout Group 646-378-2949 Gogawa@troutgroup.com
(0)
(0)